M+G LS -,05/ GB00BKFB1C65 /
9/5/2024 8:01:49 AM | Chg. 0.0000 | Volume | Bid9:34:40 AM | Ask9:34:40 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.5140EUR | 0.00% | 0 Turnover: 0.0000 |
2.5060Bid Size: 5,000 | 2.5460Ask Size: 5,000 | 6.26 mill.EUR | - | - |
GlobeNewswire
8/31
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates
GlobeNewswire
8/28
Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
GlobeNewswire
8/27
AMN Healthcare Introduces Strategic Partnership Solutions – First In-House Full-Service Language Ser...
GlobeNewswire
8/22
Mount Sinai Health System Partners with Pickleball Organization CityPickle to Promote Health, Physic...
GlobeNewswire
8/8
Association of Corporate Counsel Launches New Well-being Toolkit for In-house Lawyers
GlobeNewswire
8/7
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results
GlobeNewswire
8/7
Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update an...
GlobeNewswire
8/1
Elevar Therapeutics Granted Orphan Medicinal Product Designation by the European Medicines Agency fo...
GlobeNewswire
7/29
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Eva...
GlobeNewswire
7/26
Ipsen receives CHMP positive opinions for Iqirvo® (elafibranor) in Primary Biliary Cholangitis and K...
GlobeNewswire
7/23
Aledade and eClinicalWorks Partner to Enhance Physician Experience through Ambient Listening Technol...
GlobeNewswire
7/15
NYSIF Expands Innovative Claim Mobile App; Now Available for Disability Benefits and Paid Family Lea...
GlobeNewswire
7/9
Elevar Therapeutics Reports Plans for Near-Term Resubmission of NDA for First-Line Treatment Option ...
GlobeNewswire
7/9
Strong Proof-of-Concept Data from Phase 2 Trial of PDE10A Inhibitor (CPL’36), a Novel Oral Antipsych...
GlobeNewswire
7/1
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...